Left Ventricular Assist Device as Bridge to Recovery for Anthracycline-Induced Terminal Heart Failure
| Autor: | Jon M Appel, Peter Bo Hansen, Kåre Sander, Jacob E. Møller, Anders Krarup-Hansen, Finn Gustafsson |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Heart transplantation
medicine.medical_specialty Cardiotoxicity Poor prognosis Anthracycline business.industry medicine.medical_treatment Emergency Nursing medicine.disease Surgery Bridge (graph theory) Ventricular assist device Internal medicine Heart failure Emergency Medicine medicine Cardiology Sarcoma Cardiology and Cardiovascular Medicine business |
| Zdroj: | Congestive Heart Failure. 18:291-294 |
| ISSN: | 1527-5299 |
| Popis: | Anthracycline treatments are hampered by dose-related cardiotoxicity, frequently leading to heart failure (HF) with a very poor prognosis. The authors report a case of a 19-year-old man developing HF after anthracycline treatment for Ewing sarcoma. Despite medical treatment, his condition deteriorated to terminal HF, leading to implantation of a mechanical left ventricular assist device (LVAD). His heart function recovered, allowing explantation of the device 14 months after implantation. Heart transplantation is often contraindicated in the first years after treatment for cancers, and LVAD as "bridge to recovery" may be warranted in similar patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text